GlassScriptPhysician profile
Stephanie E Ivey
NPI 1336406503
$734.09
in general payments reported to CMS, 2019-2025
25 companies · $121 in 2025
The $121 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $80.43 · 2022: $124 · 2023: $219 · 2024: $190 · 2025: $121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $530.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $529.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $116.07 | 2022-2025 | Keytruda, Lynparza |
| Rti Surgical, INC | $62.01 | 2023 | |
| Kowa Pharmaceuticals America, INC. | $60.55 | 2023 | Seglentis |
| Tempus Ai, INC | $45.11 | 2024 | |
| Eisai INC. | $40.24 | 2021-2022 | |
| Smith+Nephew, INC. | $38.86 | 2023-2025 | Renasys Touch, Renasys Go V2 Home |
| Organogenesis INC. | $31.98 | 2024 | Puraply Am |
| Kci USA, INC. | $30.56 | 2021-2022 | |
| Corcept Therapeutics | $27.79 | 2024 | Korlym |
| Regeneron Healthcare Solutions, INC. | $27.15 | 2024 | Libtayo |
| Hologic INC | $22.16 | 2022 | |
| Boston Scientific Corporation | $21.63 | 2023 | |
| Daiichi Sankyo INC. | $21.24 | 2023 | Injectafer |
| Solventum Corporation | $20.32 | 2025 | Promogran Prisma |
| Abbvie INC. | $18.37 | 2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aroa Biosurgery Incorporated | $16.41 | 2025 | |
| Davol INC. | $16.32 | 2021 | |
| Kerecis Limited | $16.26 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Integra Lifesciences Corporation | $15.62 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Tactile Systems Technology INC | $15.57 | 2021 | |
| Intra-Sana Laboratories | $15.18 | 2024 | Reltone 200 Mg, Glycate, Reltone 400 Mg |
| Hologic Sales and Service, LLC | $14.40 | 2023 | Trunode, Localizer, Biozorb |
| Novo Nordisk INC | $14.31 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $13.49 | 2022 | |
| Reprise Biomedical, INC. | $12.49 | 2025 | Miro3d |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Ivey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.